This genotype also demonstrated resistance to high-fat diet induced hypercholesterolemia and insulin resistance in the absence of body weight effects, suggesting a direct beneficial metabolic effect of myeloid-PTP1B ablation in the context of dyslipidaemia-induced atherosclerosis [14]. The gene discussed is PTPN1; the disease is Insulin resistance.